{
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "complex_factors": [
        "5x leverage",
        "Synthetic replication",
        "Use of collateralised structure",
        "Daily leverage rebalancing and compounding effect",
        "Counterparty risk exposure",
        "High risk rating (6/7)"
    ],
    "classification": "complex",
    "supporting_data": "The product is a Collateralised Exchange Traded Security (ETP) providing 5 times the daily performance of the iShares 7-10 Year Treasury Bond ETF, indicating significant leverage. The replication is synthetic, as the return depends on the performance of the Reference Asset and collateral assets held in a margin account, rather than direct physical ownership of underlying securities. The document references a collateralised structure and margin account, implying use of derivatives and swap agreements to achieve the leveraged exposure. The product explicitly warns about the compounding effect due to daily leverage rebalancing, which increases complexity and risk. The risk indicator is 6 out of 7, indicating a very high risk level. The product is not UCITS compliant and is intended for sophisticated investors able to monitor their investment frequently. There is no capital protection, and the product may be difficult to understand for retail investors. The presence of leverage, synthetic replication, collateralised structure, and derivative use (swaps) are all complexity flags under MiFID II. The product\u2019s complexity is further supported by the high risk rating, the compounding effect, and the lack of capital protection. No inverse exposure is indicated. The PRIIPs KID and factsheet (though not fully provided here) typically reinforce these points, including the comprehension warning and the complexity of the leveraged daily return strategy."
}